One GWAs in 456 Japanese patients with chronic hepatitis C identified TLL1 as a novel susceptibility locus for hepatocellular carcinoma (HCC) after HCV clearance following interferon- based treatment [149]. Here, TLL1 is linked to hepatocellular carcinoma.